» Articles » PMID: 32446978

30-day Mortality in Patients Hospitalized with COVID-19 During the First Wave of the Italian Epidemic: A Prospective Cohort Study

Abstract

Italy was the first European country hit by the COVID-19 pandemic and has the highest number of recorded COVID-19 deaths in Europe. This prospective cohort study of the correlates of the risk of death in COVID-19 patients was conducted at the Infectious Diseases and Intensive Care units of Luigi Sacco Hospital, Milan, Italy. The clinical characteristics of all the COVID-19 patients hospitalised in the early days of the epidemic (21 February -19 March 2020) were recorded upon admission, and the time-dependent probability of death was evaluated using the Kaplan-Meier method (censored as of 20 April 2020). Cox proportional hazard models were used to assess the factors independently associated with the risk of death. Forty-eight (20.6 %) of the 233 patients followed up for a median of 40 days (interquartile range 33-47) died during the follow-up. Most were males (69.1 %) and their median age was 61 years (IQR 50-72). The time-dependent probability of death was 19.7 % (95 % CI 14.6-24.9 %) 30 days after hospital admission. Age (adjusted hazard ratio [aHR] 2.08, 95 % CI 1.48-2.92 per ten years more) and obesity (aHR 3.04, 95 % CI 1.42-6.49) were independently associated with an increased risk of death, which was also associated with critical disease (aHR 8.26, 95 % CI 1.41-48.29), C-reactive protein levels (aHR 1.17, 95 % CI 1.02-1.35 per 50 mg/L more) and creatinine kinase levels above 185 U/L (aHR 2.58, 95 % CI 1.37-4.87) upon admission. Case-fatality rate of patients hospitalized with COVID-19 in the early days of the Italian epidemic was about 20 %. Our study adds evidence to the notion that older age, obesity and more advanced illness are factors associated to an increased risk of death among patients hospitalized with COVID-19.

Citing Articles

Metabolic health is more strongly associated with the severity and mortality of coronavirus disease 2019 than obesity.

Koo H, Lee J, Lee J, Lee H Arch Public Health. 2024; 82(1):131.

PMID: 39180113 PMC: 11342616. DOI: 10.1186/s13690-024-01372-8.


Mismanagement of SARS-CoV-2 Infection Pre Hospitalisation during the Omicron Era: Antibiotics and Steroids Instead of Early Antivirals.

Giacomelli A, Ciubotariu C, Zacheo M, Rabbione A, Pieruzzi M, Barone F Viruses. 2024; 16(7).

PMID: 39066168 PMC: 11281468. DOI: 10.3390/v16071005.


Association between chest X-ray score and clinical outcome in COVID-19 patients: A study on modified radiographic assessment of lung edema score (mRALE) in Indonesia.

Rahayu D, Rusli M, Bramantono B, Widyoningroem A Narra J. 2024; 4(1):e691.

PMID: 38798849 PMC: 11125424. DOI: 10.52225/narra.v4i1.691.


Major Bleeding Events in Hospitalized COVID-19 Patients: A Retrospective Observational Study.

Poloni A, Casalini G, Pozza G, Giacomelli A, Colaneri M, Carrozzo G Medicina (Kaunas). 2024; 60(5).

PMID: 38792997 PMC: 11122796. DOI: 10.3390/medicina60050814.


Factors related to mortality of patients with COVID-19 who are admitted to the ICU: Prognostic mortality factors of COVID-19 patients.

Alvarez-Macias A, Ubeda-Iglesias A, Macias-Seda J, Gomez-Salgado J Medicine (Baltimore). 2024; 103(21):e38266.

PMID: 38787973 PMC: 11124599. DOI: 10.1097/MD.0000000000038266.


References
1.
Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D . Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis. 2020; 71(15):706-712. PMC: 7108195. DOI: 10.1093/cid/ciaa199. View

2.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

3.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

4.
Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View

5.
Wenham C, Smith J, Morgan R . COVID-19: the gendered impacts of the outbreak. Lancet. 2020; 395(10227):846-848. PMC: 7124625. DOI: 10.1016/S0140-6736(20)30526-2. View